Health Canada inspection
Boehringer Ingelheim (Canada) Ltd Ltee: Health Canada inspection of Mar 31, 2017
Health Canada · GMP · rating C
Key facts
| Establishment | Boehringer Ingelheim (Canada) Ltd Ltee |
|---|---|
| City | Burlington |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Mar 28, 2017 |
| End date | Mar 31, 2017 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 100187 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.